Letter to the Editor on "Rivaroxaban Use for Thrombosis Prophylaxis is Associated With Early Periprosthetic Joint Infection"
- PMID: 27329579
- DOI: 10.1016/j.arth.2016.05.018
Letter to the Editor on "Rivaroxaban Use for Thrombosis Prophylaxis is Associated With Early Periprosthetic Joint Infection"
Comment in
-
Response to Letter to the Editor on "Rivaroxaban Use for Thromboprophylaxis Is Associated With Early Periprosthetic Joint Infection".J Arthroplasty. 2016 Sep;31(9):2079-80. doi: 10.1016/j.arth.2016.05.017. Epub 2016 May 18. J Arthroplasty. 2016. PMID: 27341972 No abstract available.
Comment on
-
Rivaroxaban Use for Thrombosis Prophylaxis Is Associated With Early Periprosthetic Joint Infection.J Arthroplasty. 2016 Jun;31(6):1295-1298. doi: 10.1016/j.arth.2015.12.027. Epub 2015 Dec 20. J Arthroplasty. 2016. PMID: 26796776
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical